FAST NEWS: SSY Group Signs Preliminary Deal to Make Fever Medication
The latest: SSY Group Ltd. (2005.HK) said on Sunday it signed a letter of intent with a well-known Chinese pharmaceutical company to produce 1 billion to 2.5 billion ibuprofen sustained-release…
RELATED ARTICLES
-
Earnings blow for CSPC Pharma as the state drives a hard bargain
1093.HK - Riding on space fever, Adaspace rockets towards Hong Kong listing
-
iMotion Automotive rides DeepSeek fever to new fundraising
1274.HK
-
Xuanzhu Biopharm set for spin-off in Hong Kong IPO
0460.HK
-
Zhengye Biotech’s ‘pet-sized’ IPO leaves plenty of room for more fundraising
ZYBT.US
